LOOK-UP: Active pharmacovigilance study of the medicine Rinvoq™ (upadacitinib)

ENCePP Code of conduct

Yes

ENCePP Seal

This study has been awarded the ENCePP seal

Conflicts of interest of investigators

DeclarationofInterests-Annex5_signed.pdf

Composition of steering group and observers

Composition of Steering Group and Observers_signed.pdf

Signed code of conduct

ENCePPCoCAnnex3_DeclarationofcompliancewiththeENCePPCodeofConduct_signed.pdf

Signed code of conduct checklist

ENCePPCoCAnnex2_ChecklistofCodeofConduct_signed.pdf

Signed checklist for study protocols

ENCePPChecklistforStudyProtocols_signed.pdf

Data sources

• Data sources (types):
  Administrative healthcare records (e.g., claims)

  Electronic healthcare records (EHR)

  Non-interventional study

  Patient surveys

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Yes
• Check completeness:
  Yes
• Check stability:
  Yes
• Check logical consistency:
  Yes

Data characterisation

• Data characterisation conducted:
  Not applicable